Compounds > monoethylglycinexylidide
Page last updated: 2024-08-22

monoethylglycinexylidide and Sepsis

monoethylglycinexylidide has been researched along with Sepsis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, VW; Igonin, AA; Kukes, VG; Oellerich, M; Shipkova, M1
Jakob, SM; Rosenberg, PH; Ruokonen, E; Takala, J1

Trials

1 trial(s) available for monoethylglycinexylidide and Sepsis

ArticleYear
The monoethylglycinexylidide (MEGX) test as a marker of hepatic dysfunction in septic patients with pneumonia.
    Clinical chemistry and laboratory medicine, 2000, Volume: 38, Issue:11

    Topics: Adult; Aged; Biomarkers; Cytokines; Female; Humans; Lidocaine; Liver; Male; Middle Aged; Pneumonia; Sepsis

2000

Other Studies

1 other study(ies) available for monoethylglycinexylidide and Sepsis

ArticleYear
Effect of dopamine-induced changes in splanchnic blood flow on MEGX production from lidocaine in septic and cardiac surgery patients.
    Shock (Augusta, Ga.), 2002, Volume: 18, Issue:1

    Topics: Adult; Aged; Dopamine; Female; Humans; Lidocaine; Male; Middle Aged; Sepsis; Splanchnic Circulation; Thoracic Surgery

2002